Roche in take-over deal with GenMark Diagnostics
Roche to acquire GenMark Diagnostics, Inc., to access platform to test for broad range of pathogens with one patient sample.
Roche to acquire GenMark Diagnostics, Inc., to access platform to test for broad range of pathogens with one patient sample.
While media reports suggest AstraZenecas COVID-19 jab might have caused blot clots, the EMA didn’t confirm a causal relationship.
Swiss Roche AG has missed the primary endpoint in the REMDACTA trial in patients with severe COVID-19 pneumonia.
Danish sustainable crop protection company, BioPhero AS, has raised $17m in Series A funding led by DCVC Bio.
German researchers have presented a new method to assess on-target and off-target effects of CRISPR-Cas nucleases or TALENs.
EMAs human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russias Gamaleya National Centre of Epidemiology and Microbiology.
Chemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels.
Kurma Parnters and Francee investment bank have launched a 50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies.
British Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline.
The European Commission is set to fund ten "European Partnerships" partnered with different industries with 10bn.